ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,186, issued on Oct. 20, was assigned to Staidson (Beijing) Biopharmaceuticals Co. Ltd. (Beijing). "Nerve growth factor mutant" was invented... Read More
ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,187, issued on Oct. 20, was assigned to CYCURIA THERAPEUTICS GMBH (Graz, Austria). "Lymphotoxin alpha for use in therapy of myeloid leukemi... Read More
ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,188, issued on Oct. 20, was assigned to Karyopharm Therapeutics Inc. (Newton, Mass.). "Uses of IL-12 as a replacement immunotherapeutic" wa... Read More
ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,189, issued on Oct. 20, was assigned to Endo Biologics Ltd. (Dublin). "Methods of treating plantar fibromatosis" was invented by James P. T... Read More
ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,190, issued on Oct. 20, was assigned to ENTEROME S.A. (Paris). "Antigenic peptides for prevention and treatment of cancer" was invented by ... Read More
ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,191, issued on Oct. 20, was assigned to NantCell Inc. (Culver City, Calif.). "Peptide therapeutics against SARS-COV-2 spike protein" was in... Read More
ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,192, issued on Oct. 20, was assigned to Legend Biotech Ireland Ltd. (Dublin) and Legend Biotech USA Inc.. "Antibodies and chimeric antigen ... Read More
ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,193, issued on Oct. 20, was assigned to Beijing Neurosurgical Institute (Beijing). "Anti-CD133 single-chain antibody and use thereof in pre... Read More
ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,194, issued on Oct. 20, was assigned to NIPPON CHEMIPHAR Co. LTD. (Tokyo). "Citrate-containing composition, production method and dry metho... Read More
ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,195, issued on Oct. 20, was assigned to Takeda Pharmaceutical Co. Ltd. (Osaka, Japan). "Methods for treatment using anti-Alpha4Beta7 antibo... Read More